University of Chicago Medical Center, Chicago, IL.
Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Am J Surg Pathol. 2021 Aug 1;45(8):1061-1074. doi: 10.1097/PAS.0000000000001677.
We describe 22 examples of a novel, usually paratubal, adnexal tumor associated with Peutz-Jeghers syndrome in nearly 50% of cases that harbored STK11 alterations in all tested (n=21). The patients ranged from 17 to 66 years (median=39 y) and the tumors from 4.5 to 25.5 cm (median=11 cm). Most (n=18) were paratubal, with metastases noted in 11/22 (50%) and recurrences in 12/15 (80%). Morphologically, they were characterized by interanastomosing cords and trabeculae of predominantly epithelioid cells, set in a variably prominent myxoid to focally edematous stroma, that often merged to form tubular, cystic, cribriform, and microacinar formations, reminiscent of salivary gland-type tumors. The tumor cells were uniformly atypical, often with prominent nucleoli and a variable mitotic index (median=9/10 HPFs). The tumors were usually positive to a variable extent for epithelial (CAM5.2, AE1/AE3, cytokeratin 7), sex cord (calretinin, inhibin, WT1), and mesothelial (calretinin, D2-40) markers, as well as hormone receptors. PAX8, SF1, and GATA-3 were rarely positive, while claudin-4, FOXL2, and TTF-1 were consistently negative. All sequenced tumors (n=21) harbored alterations in STK11, often with a loss of heterozygosity event. There were no other recurrently mutated genes. Recurrent copy number alterations included loss of 1p and 11q, and gain of 1q, 15q, and 15p. Despite an extensive morphologic, immunohistochemical, and molecular evaluation, we are unable to determine with certainty the histogenesis of this unique tumor. Wolffian, sex cord stromal, epithelial, and mesothelial origins were considered. We propose the term STK11 adnexal tumor to describe this novel entity and emphasize the importance of genetic counseling in these patients as a significant number of neoplasms occur in association with Peutz-Jeghers syndrome.
我们描述了 22 例与 Peutz-Jeghers 综合征相关的新型通常位于副输卵管旁的附件肿瘤,这些肿瘤在所有检测到的病例中(n=21)几乎有一半存在 STK11 改变。患者年龄为 17 至 66 岁(中位数=39 岁),肿瘤大小为 4.5 至 25.5cm(中位数=11cm)。大多数(n=18)为副输卵管旁,11/22(50%)有转移,12/15(80%)有复发。形态上,它们的特点是由主要为上皮样细胞的相互吻合的条索和小梁组成,位于不同程度突出的黏液样至局灶性水肿基质中,常融合形成管状、囊性、筛状和微囊状结构,类似于唾液腺型肿瘤。肿瘤细胞均为均匀非典型性,常伴有明显的核仁,有不同程度的有丝分裂指数(中位数=9/10HPFs)。肿瘤通常不同程度地表达上皮(CAM5.2、AE1/AE3、细胞角蛋白 7)、性索(钙视网膜蛋白、抑制素、WT1)和间皮(钙视网膜蛋白、D2-40)标志物,以及激素受体。PAX8、SF1 和 GATA-3 很少阳性,而 Claudin-4、FOXL2 和 TTF-1 始终阴性。所有测序的肿瘤(n=21)均存在 STK11 改变,常伴有杂合性缺失事件。没有其他经常发生突变的基因。反复出现的拷贝数改变包括 1p 和 11q 的缺失,以及 1q、15q 和 15p 的获得。尽管进行了广泛的形态学、免疫组织化学和分子评估,我们仍无法确定这种独特肿瘤的确切组织发生。考虑了沃夫氏管、性索基质、上皮和间皮来源。我们提出 STK11 附件肿瘤一词来描述这种新实体,并强调对这些患者进行遗传咨询的重要性,因为大量肿瘤与 Peutz-Jeghers 综合征相关。